Market Exclusive

Analyst Activity – Janney Montgomery Scott Reiterates Hold on AMAG Pharmaceuticals (NASDAQ:AMAG)

Analyst Ratings For AMAG Pharmaceuticals (NASDAQ:AMAG)

Today, Janney Montgomery Scott reiterated its Hold rating on AMAG Pharmaceuticals (NASDAQ:AMAG).

There are 1 sell rating, 9 hold ratings, 3 buy ratings on the stock.

The current consensus rating on AMAG Pharmaceuticals (NASDAQ:AMAG) is Hold (Score: 2.15) with a consensus target price of $28.27 per share, a potential 69.81% upside.

Some recent analyst ratings include


Recent Trading Activity for AMAG Pharmaceuticals (NASDAQ:AMAG)
Shares of AMAG Pharmaceuticals closed the previous trading session at with shares trading hands.

Exit mobile version